The impact of age on complications, survival, and cause of death following colon cancer surgery.

BACKGROUND: Given scarce data regarding the relationship among age, complications, and survival beyond the 30-day postoperative period for oncology patients in the United States, this study identified age-related differences in complications and the rate and cause of 1-year mortality following colon cancer surgery.
METHODS: The NY State Cancer Registry and Statewide Planning and Research Cooperative System identified stage I-III colon cancer resections (2004-2011). Multivariable logistic regression and survival analyses assessed the relationship among age (<65, 65-74, ⩾75), complications, 1-year survival, and cause of death.
RESULTS: Among 24 426 patients surviving >30 days, 1-year mortality was 8.5%. Older age groups had higher complication rates, and older age and complications were independently associated with 1-year mortality (P<0.0001). Increasing age was associated with a decrease in the proportion of deaths from colon cancer with a concomitant increase in the proportion of deaths from cardiovascular disease. Older age and sepsis were independently associated with higher risk of colon cancer-specific death (65-74: HR=1.59, 95% CI=1.26-2.00; ⩾75: HR=2.57, 95% CI=2.09-3.16; sepsis: HR=2.58, 95% CI=2.13-3.11) and cardiovascular disease-specific death (65-74: HR=3.72, 95% CI=2.29-6.05; ⩾75: HR=7.02, 95% CI=4.44-11.10; sepsis: HR=2.33, 95% CI=1.81-2.99).
CONCLUSIONS: Older age and sepsis are associated with higher 1-year overall, cancer-specific, and cardiovascular-specific mortality, highlighting the importance of geriatric assessment, multidisciplinary care, and cardiovascular optimisation for older patients and those with infectious complications.

Given that colorectal cancer is the second-leading cause of cancer-related death and that the older population continues to grow in the United States, it is anticipated that the number of older patients with colon cancer will increase (Siegel ). In fact, approximately two-thirds of cancer survivors will be ⩾65 years old by the year 2020 (Mohile ). Postoperative mortality is an important outcome measure following colon cancer surgery, especially for high-risk groups such as the elderly. However, while most studies in the United States have focused on 30-day postoperative mortality as an end point, there is increasing evidence from Europe to suggest that there is high mortality beyond 30 days in the older population (Gooiker ; Mamidanna ; Byrne ). In fact, this excess postoperative mortality has been shown to endure up to 1 year following surgery and has been suggested to be the most important explanatory factor for age-related differences in long-term colorectal cancer survival (Dekker ).

Although only a limited number of studies have examined postoperative mortality beyond 30 days, there is even less data regarding age-related differences in complications and cause of death at 1 year. In the only population-based study investigating 1-year mortality and cause of death, Dekker et al observed that mortality increased with age and 25% of deaths were attributable to complications among 1924 patients who underwent stage I–III colorectal cancer resection in The Netherlands (Dekker ). Furthermore, older patients may be at higher risk for septic complications, and there is increasing evidence that sepsis is associated with worse long-term survival following colorectal cancer surgery as well as an increased risk of cardiovascular events due to a sepsis-mediated systemic inflammatory response (Yende ; Aquina ; Ou ; Park ). However, no similar studies to date have been performed in the United States.

Evaluating the association among age, complications, long-term mortality, and cause of death may help identify patients at risk for adverse outcomes and guide both preoperative and postoperative strategies to optimise these high-risk patients. For example, the use of preoperative comprehensive geriatric assessment (CGA) to assess frailty and stratify risk has been shown to reduce the rate of complications, decrease hospital length of stay, and improve long-term quality of life (Huddleston ; Ellis ; Partridge ). Prehabilitation, or strategies to optimise preoperative functional capacity in at-risk patients, can improve the rate of return to baseline functional status following surgery (Gillis ). Finally, postoperative multidisciplinary care with comanagement by geriatricians for older patients has been shown to decrease the rate of complications, reduce length of stay, and increase the rate of chemotherapy completion for oncology patients (Huddleston ; Partridge ). However, it remains unclear as to which patients would most benefit from these interventions.

Given the scarce amount of data regarding 1-year mortality and cause of death in the United States, the aim of this present study was to examine age-related differences in postoperative complications, 1-year survival, and cause-specific mortality among patients in New York State using a linked population-based dataset between the state cancer registry and state hospital discharge database. Our hypothesis was that older age would be associated with higher odds of a postoperative complication, higher risk of 1-year mortality, and higher risk of both colon cancer cause-specific mortality and cardiovascular disease cause-specific mortality. This information could help direct the utilisation of CGA, prehabilitation, and multidisciplinary care for high-risk patients.

Materials and methods

NYSCR and SPARCS

The New York State Cancer Registry (NYSCR) and Statewide Planning and Research Cooperative System (SPARCS) were utilised for this study. The NYSCR has received the highest certification from the North American Association of Central Cancer Registries, and SPARCS is an all-payer hospital discharge database that contains patient-level data on all non-Veteran Affairs hospital admissions, ambulatory surgery procedures, and emergency department visits in New York State and has been used extensively for research purposes (Boscoe ; Aquina , 2015b, 2015c, 2015d; Iannuzzi ; Aquina , 2016c, 2016d). The NYSCR is linked to Vital Records and the National Death Index to provide the cause and date of death for patients.

Study cohort selection

Patients who underwent colectomy (ICD-9=17.31–17.39, 45.71–45.79, or 45.8–45.83) for stage I–III colon adenocarcinoma (site ICD-O-3=C180, C182–C189, C199, or SEER site recode=21041–21051; histology=8140, 8210–8221, 8260–8263, or 8470–8490) diagnosed from 2004–2011 were identified within the NYSCR and SPARCS. Patients were excluded if they had missing data related to adjuvant therapy, the unique surgeon identifier, surgeon board-certification status, surgeon year of training completion, or TNM staging or if they died within 30 days of surgery.

Outcomes

The primary outcome was 1-year overall survival following surgery. Survival follow-up was complete through 31 December 2012, so each patient in the study cohort had 1 year of potential follow-up. Secondary outcomes included postoperative complications, cause of death, and 1-year cause-specific survival. Postoperative complications (anastomotic leak/gastrointestinal complication, abdominal abscess, surgical site infection, pneumonia, sepsis, pulmonary failure, myocardial infarction, venous thromboembolism, acute renal failure, gastrointestinal bleeding, and haemorrhage) were identified during the index admission as a diagnosis ‘not present-on-admission' or upon readmission to any non-Veteran Affairs hospital in New York State within 30 days of surgery. For the cause-specific survival analyses, patients who died from a different cause were informatively censored on the date of death. The ICD-9 and ICD-10 codes used to identify complications and causes of death are listed in Supplementary Table 1.

Additional covariates

Patient factors considered for the analyses included age (<65, 65–74, >75), sex, insurance type, and unscheduled admission as defined by SPARCS. Elixhauser comorbidities were identified as present-on-admission for the index admission as well as any inpatient admission in the prior year to increase the capture rate of comorbidities (Quan ). Oncologic factors included TNM/AJCC staging, tumour grade, and receipt of adjuvant chemotherapy. Operative factors included type of colectomy (left, right, partial, and total), a minimally invasive approach (ICD-9=17.31–17.39, 17.42, 45.81, 48.42, 48.51, 54.21, 54.51, or V64.41), and year of surgery.

Surgeon characteristics included board-certification type (surgery or colorectal surgery), years of experience, and annual colon cancer resection volume. Information on board-certification and year of residency/fellowship completion were obtained from the American Medical Association Masterfile and American Board of Medical Specialties databases. Surgeon annual colon cancer resection volume was characterised into tertiles (low, medium, and high volume).

Hospital factors included academic status, location, and annual colon cancer resection volume. Academic status was based upon the Council of Teaching Hospitals designation as obtained from the American Hospital Association Annual Survey. Urban or rural hospital location was based upon the definition by the US Office of Management and Budget (2013). Hospital annual colon cancer resection volume was characterised into tertiles (low, medium, and high volume).

Statistical analysis

Factors were compared by outcome using χ2-square test, Kaplan–Meier, and Cochran–Armitage test for trend analyses as appropriate to the data. Factors with P<0.1 on bivariate analysis were manually entered in multivariable analyses. Three-level mixed-effects multivariable analyses were performed to account for clustering of patients among surgeons and hospitals. Logistic regression analysis was utilised for the outcome of a postoperative complication, Cox proportional-hazards analysis was used for 1-year overall survival, and competing-risks analysis was used for cause-specific survival (Katsahian ). The R packages glmer (logistic regression), coxme (Cox proportional-hazards), and frailtyPack (competing-risks) were used for the analyses (R version 3.2.5, R Foundation for Statistical Computing). SAS, Version 9.2 (SAS Institute, Cary, NC, USA) was used for all other analyses. The study was approved by the University of Rochester Medical Center (IRB #00054886) and New York Department of Health (DPRB #1412-05) institutional review boards.

Results

Cohort characteristics

A total of 30 700 patients underwent stage I–III colon cancer resection of which 24 426 patients met inclusion criteria. Of those excluded, 1224 had missing adjuvant therapy data, 11 had a missing unique surgeon identifier, 2986 had missing or no surgeon board-certification or year of training completion, and 59 had missing TNM staging. In addition, 883 (3.3%) patients died within 30 days of surgery. The mean time of follow-up was 349 days (s.d. ±61 days) with a total of 24 426 person-years of follow-up.

The study cohort characteristics by age group are presented in Table 1. Age ⩾75 comprised the largest age group (44%) followed by the <65 (32%) and 65–74 (24%) age groups. Older patients were more likely to be female, of white race, and have higher comorbidity burden. They were also more likely to have an unscheduled admission for the colectomy, undergo an open operative approach, and have surgery at a non-academic or rural hospital. They were less likely to have stage III disease and receive adjuvant chemotherapy for stage III disease. Patients who had a postoperative complication were also less likely to receive chemotherapy for stage III disease (39.4% vs 58.8%, P<0.0001).

Table 1

Patient, surgeon, and hospital characteristics and outcomes by age group

Factors	Age <65 (N=8176) (32%)	Age 65–74 (N=6252) (24%)	Age ⩾75 (N=11 109) (44%)	P-value
Patient factors
Sex
Male	4192 (51.3)	3059 (48.9)	4454 (40.1)	<0.0001
Female	3984 (48.7)	3193 (51.1)	6655 (59.9)
Race
White	5177 (63.3)	4523 (72.3)	9111 (82.0)	<0.0001
Black	1427 (17.5)	843 (13.5)	876 (7.9)
Other	1291 (15.8)	708 (11.3)	806 (7.3)
Unknown	281 (3.4)	178 (2.9)	316 (2.8)
Medicaid Insurance	2723 (33.3)	1711 (27.4)	3211 (28.9)	<0.0001
Comorbidities
Hypertension	3428 (41.9)	3968 (63.5)	7834 (70.5)	<0.0001
Congestive heart failure	213 (2.6)	501 (8.0)	1696 (15.3)	<0.0001
Diabetes mellitus	1381 (16.9)	1676 (26.8)	2498 (22.5)	<0.0001
Chronic obstructive pulmonary disease	886 (10.8)	1217 (19.5)	2230 (20.1)	<0.0001
Peripheral vascular disease	136 (1.7)	299 (4.8)	807 (7.3)	<0.0001
Renal failure	175 (2.1)	326 (5.2)	938 (8.4)	<0.0001
Liver disease	303 (3.7)	198 (3.2)	308 (2.8)	0.001
Anaemia	184 (2.2)	279 (4.5)	851 (7.7)	<0.0001
Obesity	724 (8.9)	500 (8.0)	448 (4.0)	<0.0001
Unscheduled admission	2332 (28.5)	1770 (28.3)	4360 (39.2)	<0.0001
Oncologic factors
T classification
1	1559 (19.1)	1105 (17.7)	1446 (13.0)	<0.0001
2	1217 (14.9)	1106 (17.7)	1949 (17.5)
3	4511 (55.2)	3463 (55.4)	6629 (59.7)
4	889 (10.9)	578 (9.2)	1085 (9.8)
N classification
0	5008 (61.3)	4138 (66.2)	7714 (69.4)	<0.0001
1	2087 (25.5)	1432 (22.9)	2305 (20.8)
2	1081 (13.2)	682 (10.9)	1090 (9.8)
AJCC stage
I	2331 (28.5)	1903 (30.4)	3022 (27.2)	<0.0001
II	2678 (32.8)	2236 (35.8)	4692 (42.2)
III	3167 (38.7)	2113 (33.8)	3395 (30.6)
Adjuvant chemotherapy receipt for stage III	2313 (73.0)	1318 (62.4)	1126 (33.2)	<0.0001
Operative factors
Type of colectomy
Right	3562 (43.6)	2192 (35.1)	2975 (26.8)	<0.0001
Left	4071 (49.8)	3786 (60.6)	7653 (68.9)
Partial	331 (4.0)	206 (3.3)	385 (3.5)
Total	212 (2.6)	68 (1.1)	96 (0.9)
Operative approach
Open	5765 (70.5)	4570 (73.1)	8472 (76.3)	<0.0001
Minimally invasive	2411 (29.5)	1682 (26.9)	2637 (23.7)
Year of surgery
2004–2005	2078 (25.4)	1705 (27.3)	2981 (26.8)	0.02
2006–2007	2082 (25.5)	1657 (26.5)	2892 (26.0)
2008–2009	2071 (25.3)	1481 (23.7)	2752 (24.8)
2010–2011	1945 (23.8)	1409 (22.5)	2484 (22.4)
Surgeon factors
Board-certification
Surgery	6335 (77.5)	4900 (78.4)	8878 (79.9)	0.0002
Colorectal surgery	1841 (22.5)	1352 (21.6)	2231 (20.1)
Years in practice
<5	921 (11.3)	598 (9.6)	1060 (9.5)	<0.0001
5–9	1371 (16.8)	1071 (17.1)	1705 (15.4)
10–19	2751 (33.7)	2116 (33.8)	3599 (32.4)
⩾20	3133 (38.2)	2467 (39.5)	4745 (42.7)
Annual colon cancer resection volume
Low (1–5)	2488 (30.4)	1793 (28.7)	3235 (29.1)	0.007
Medium (5–10)	2183 (26.7)	1744 (27.9)	3203 (28.8)
High (>10)	3505 (42.9)	2715 (43.4)	4671 (42.1)
Hospital Factors
Major academic center	3861 (47.2)	2811 (45.0)	4415 (39.7)	<0.0001
Location
Urban	7716 (94.4)	5812 (93.0)	10 255 (92.3)	<0.0001
Rural	460 (5.6)	440 (7.0)	854 (7.7)
Annual colon cancer resection volume
Low (1–30)	2549 (31.2)	1910 (30.6)	3483 (31.3)	0.63
Medium (31–55)	2407 (29.4)	1879 (30.0)	3339 (30.1)
High (>55)	3220 (39.4)	2463 (39.4)	4287 (38.6)
Outcomes
Major complication
Surgical site infection	610 (7.5)	503 (8.0)	855 (7.7)	0.43
Abdominal abscess	215 (2.6)	147 (2.3)	277 (2.5)	0.57
Anastomotic leak/GI complication	816 (10.0)	736 (11.8)	1422 (12.8)	<0.0001
Sepsis	225 (2.7)	263 (4.2)	626 (5.6)	<0.0001
Pneumonia	18 (0.2)	48 (0.8)	78 (0.7)	<0.0001
Pulmonary failure	210 (2.6)	350 (5.6)	928 (8.3)	<0.0001
Myocardial infarction	40 (0.5)	87 (1.4)	274 (2.5)	<0.0001
Venous thromboembolism	119 (1.5)	147 (2.3)	323 (2.9)	<0.0001
Acute renal failure	196 (2.4)	363 (5.8)	885 (8.0)	<0.0001
Gastrointestinal bleeding	149 (1.8)	177 (2.8)	642 (5.8)	<0.0001
Haemorrhage	83 (1.0)	87 (1.4)	194 (1.7)	0.0001
Any major complication	1852 (22.6)	1798 (28.8)	3945 (35.5)	<0.0001
1-Year overall mortality	226 (2.8)	401 (6.4)	1544 (13.9)	<0.0001

Abbreviation: GI=gastrointestinal.

Postoperative complications

After excluding those that died within 30 days, the complication rate for the study cohort was 29.7% (N=7595). Table 1 presents the captured frequency of each complication by age group. Sepsis was correlated with other complications that may act as sequelae of sepsis, including acute renal failure (R=0.343) and pulmonary failure (R=0.411). Increasing age was associated with a higher risk of a complication (<65=22.6% 65–74=28.8% ⩾75=35.5% P<0.0001). Factors independently associated with a complication are presented in Table 2. After controlling for patient, surgeon, and hospital characteristics, age 65–74 (odds ratio (OR)=1.34, 95% confidence interval (CI)=1.23–1.45) and age ⩾75 (OR=1.62, 95%CI=1.50–1.74) were independently associated with higher odds of a complication compared to age <65.

Table 2

Multivariable analyses of factors independently associated with postoperative complications and 1-year overall mortality

	Postoperative complication* (OR (95% CI))	1-Year overall mortality† (HR (95% CI))
Age
<65	Reference	Reference
65–75	1.34 (1.23–1.45)	2.04 (1.73–2.41
⩾75	1.62 (1.50–1.74)	3.49 (3.00–4.06)
Postoperative complication	N/A	2.17 (1.98–2.37)
Other patient factors
Sex
Female	Reference	–
Male	1.42 (1.33–1.50)	–
Race
White	Reference	Reference
Black	1.02 (0.92–1.13)	0.93 (0.80–1.07)
Other	0.88 (0.79–0.98)	0.85 (0.72–1.01)
Unknown	0.83 (0.69–1.01)	1.04 (0.79–1.36)
Medicaid insurance	1.14 (1.06–1.22)	–
Comorbidities
Hypertension	0.93 (0.88–0.99)	0.82 (0.75–0.90)
Congestive heart failure	1.46 (1.32–1.61)	1.60 (1.43–1.78)
Chronic obstructive pulmonary disease	1.27 (1.17–1.37)	1.23 (1.12–1.36)
Renal failure	2.01 (1.78–2.27)	1.39 (1.22–1.59)
Peripheral vascular disease	1.02 (0.90–1.16)	1.21 (1.04–1.41)
Liver disease	–	1.59 (1.29–1.95)
Anaemia	3.03 (2.67–3.44)	1.34 (1.18–1.52)
Unscheduled admission	2.04 (1.91–2.18)	1.93 (1.76–2.13)
Oncologic factors
AJCC stage
I	–	Reference
II	–	1.38 (1.21–1.57)
III	–	2.44 (2.14–2.79)
T classification
1	Reference	–
2	1.09 (0.98–1.21)	–
3	1.06 (0.97–1.15)	–
4	1.32 (1.17–1.48)	–
Tumour grade
1	–	Reference
2	–	1.02 (0.86–1.21)
3/4	–	1.54 (1.28–1.85)
Unknown	–	1.33 (1.01–1.75)
Receipt of adjuvant chemotherapy	–	0.57 (0.50–0.64)
Operative factors
Type of colectomy
Right	Reference	Reference
Left	0.96 (0.90–1.02)	1.03 (0.93–1.13)
Partial	1.39 (1.19 1.62)	1.15 (0.92–1.43)
Total	1.89 (1.51–2.38)	1.35 (0.94–1.92)
Operative approach
Open	Reference	Reference
Minimally invasive	0.74 (0.68–0.80)	0.79 (0.70–0.89)
Year of surgery
2004–2005	Reference	–
2006–2007	1.14 (1.05–1.23)	–
2008–2009	1.28 (1.18–1.39)	–
2010–2011	1.28 (1.17–1.41)	–
Surgeon factors
Board-certification
Surgery	Reference	Reference
Colorectal surgery	1.02 (0.91–1.14)	0.84 (0.73–0.97)
Annual colon cancer resection volume
Low (1–5)	Reference	Reference
Medium (6–10)	0.92 (0.85–1.00)	0.96 (0.86–1.07)
High (>10)	0.94 (0.86–1.03)	0.87 (0.78–0.98)
Hospital factors
Annual colon cancer resection volume
Low (1–30)	Reference	Reference
Medium (31–55)	1.18 (1.07–1.29)	0.90 (0.80–1.02)
High (>55)	1.04 (0.93–1.17)	0.93 (0.80–1.07)

Abbreviations: OR=odds ratio; HR=hazard ratio.

One-year overall survival

Of those that survived at least 30 days (N=24 426), the overall 1-year mortality rate was 8.5%. Older age (<65=2.8% 65–74=6.4% ⩾75=13.9% P<0.0001) and a postoperative complication (16.2% vs 5.2% P<0.0001) conferred higher unadjusted rates of 1-year mortality. Figure 1A displays the 1-year overall mortality rates by postoperative complication status stratified by age. In particular, sepsis had high unadjusted rates of 1-year mortality across all age groups (overall unadjusted mortality rate=35.7% Figure 1B). Table 2 presents factors independently associated with 1-year overall mortality. After controlling for patient, surgeon, and hospital characteristics, age 65–74 (hazard ratio (HR)=2.04, 95% CI=1.73–2.41), age ⩾75 (HR=3.49, 95% CI=3.00–4.06), and a complication (HR=2.17, 95% CI=1.98–2.37) were independently associated with a higher risk of 1-year overall mortality.

Figure 1

Bar graph depicting 1-year overall mortality rates by (A) postoperative complication status (yes/no) and (B) sepsis status (yes/no) stratified by age group (<65, 65–74, and ⩾75 years old).

Causes of death

Among the 2171 who died, the five most common causes of 1-year mortality in order were colon cancer (45.6%), cardiovascular disease (24.5%), another primary cancer (7.4%), respiratory disease (6.4%), and infection (3.5%). Table 3 presents the number and proportion of patients who died by cause of death stratified by AJCC stage and age group. Using a test for trend, increasing age was associated with a decrease in the proportion of patients who died from colon cancer (P=0.0002) with a concomitant increase in the proportion of patients who died from cardiovascular disease (P<0.0001). For stage I, colon cancer was the most common cause of death for the <65 age group, and cardiovascular disease was the most common cause of death for the 65–74 and ⩾75 age groups. For stage II and III, colon cancer was the most common cause of death across all age groups. Among those with sepsis (not shown in Table), colon cancer (41.5%) and cardiovascular disease (24.6%) were also the two most common causes of death.

Table 3

Causes of death at 1 year by age group and AJCC stage

Cause of death	Age <65	Age 65–74	Age ⩾75
Stage I (N=350 deaths)	(N=26)	(N=56)	(N=268)
Colon cancer	9 (34.6%)	8 (14.3%)	61 (22.8%)
Cardiovascular disease	5 (19.2%)	21 (37.5%)	108 (40.3%)
Respiratory disease	2 (7.7%)	5 (8.9%)	26 (9.7%)
Other primary cancer	3 (11.5%)	8 (14.3%)	21 (7.8%)
Infection	1 (3.8%)	4 (7.1%)	11 (4.1%)
Gastrointestinal disease	1 (3.8%)	1 (1.8%)	4 (1.5%)
Neuropsychiatric disease	0 (0%)	1 (1.8%)	6 (2.2%)
Trauma	1 (3.8%)	2 (3.6%)	5 (1.9%)
Renal disease	0 (0%)	1 (1.8%)	3 (1.1%)
Diabetes mellitus	0 (0%)	1 (1.8%)	5 (1.9%)
Other cause	2 (7.7%)	1 (1.8%)	5 (1.9%)
Unknown cause	2 (7.7%)	3 (5.4%)	13 (4.8%)
Stage II (N=801 deaths)	(N=70)	(N=127)	(N=604)
Colon cancer	32 (45.7%)	50 (39.4%)	222 (36.7%)
Cardiovascular disease	6 (8.6%)	28 (22.0%)	204 (33.8%)
Respiratory disease	4 (5.7%)	6 (4.7%)	50 (8.3%)
Other primary cancer	10 (14.3%)	15 (11.8%)	39 (6.5%)
Infection	2 (2.9%)	4 (3.1%)	25 (4.1%)
Gastrointestinal disease	4 (5.7%)	8 (6.3%)	10 (1.7%)
Neuropsychiatric disease	1 (1.4%)	4 (3.1%)	5 (0.8%)
Trauma	1 (1.4%)	2 (1.6%)	8 (1.3%)
Renal disease	2 (2.9%)	1 (0.8%)	3 (0.5%)
Diabetes mellitus	3 (4.3%)	3 (2.4%)	5 (0.8%)
Other cause	2 (2.9%)	2 (1.6%)	6 (1.0%)
Unknown cause	3 (4.3%)	4 (3.1%)	27 (4.5%)
Stage III (N=1020 deaths)	(N=130)	(N=218)	(N=672)
Colon cancer	90 (69.2%)	123 (56.4%)	395 (58.8%)
Cardiovascular disease	10 (7.7%)	34 (15.6%)	117 (17.4%)
Respiratory disease	4 (3.1%)	11 (5.0%)	30 (4.5%)
Other primary cancer	9 (6.9%)	15 (6.9%)	40 (5.9%)
Infection	3 (2.3%)	12 (5.5%)	14 (2.1%)
Gastrointestinal disease	3 (2.3%)	4 (1.8%)	13 (1.9%)
Neuropsychiatric disease	0 (0%)	0 (0%)	12 (1.9%)
Trauma	3 (2.3%)	1 (0.5%)	5 (0.7%)
Renal disease	0 (0%)	0 (0%)	7 (1.0%)
Diabetes mellitus	2 (1.5%)	4 (1.8%)	6 (0.9%)
Other cause	1 (0.8%)	4 (1.8%)	28 (0.7%)
Unknown cause	5 (3.8%)	10 (4.6%)	28 (4.2%)

One-year cause-specific survival

Competing-risks multivariable analyses were performed for 1-year colon cancer mortality and cardiovascular disease mortality since these were the two most common causes of death. The results of these analyses are shown in Table 4. Of note, older age and the infectious complications of sepsis, pneumonia, and abdominal abscess were independent risk factors for death from colon cancer. For death from cardiovascular disease, older age, sepsis, and pneumonia were independent risk factors.

Table 4

Multivariable analysis of factors independently associated with 1-year cause-specific mortality

	Death from colon cancer (hazard ratio (95% CI))	Death from cardiovascular disease (hazard ratio (95% CI))
Age
<65	Reference	Reference
65–74	1.59 (1.26–2.00)	3.72 (2.29–6.05)
⩾75	2.57 (2.09–3.16)	7.02 (4.44–11.10)
Postoperative complication
Sepsis	2.58 (2.13–3.11)	2.33 (1.81–2.99)
Pneumonia	2.15 (1.39–3.34)	2.37 (1.44–3.89)
Abdominal abscess	1.57 (1.18–2.08)	1.19 (0.77–1.84)
Myocardial infarction	1.49 (1.10–2.03)	1.59 (1.12–2.25)
Gastrointestinal bleeding	1.08 (0.85–1.37)	1.42 (1.08–1.86)
Other patient factors
Comorbidities
Congestive heart failure	1.20 (1.01–1.43)	2.38 (1.95–2.91)
Peripheral vascular disease	0.96 (0.74–1.24)	1.86 (1.44–2.41)
Renal failure	1.11 (0.88–1.39)	1.73 (1.35–2.21)
Anaemia	1.53 (1.27–1.84)	1.03 (0.79–1.34)
Unscheduled admission	1.85 (1.59–2.14)	1.51 (1.23–1.84)
Blood transfusion	1.16 (1.01–1.34)	1.19 (0.98–1.44)
Discharge to healthcare facility	1.50 (1.29–1.75)	2.68 (2.19–3.27)
Oncologic factors
AJCC stage
I	Reference	Reference
II	2.14 (1.66–2.77)	1.10 (0.89–1.37)
III	5.40 (4.20–6.94)	0.97 (0.77–1.23)
Tumour grade
1	Reference	–
2	1.06 (0.78–1.42)	–
3/4	2.24 (1.65–3.04)	–
Unknown	2.01 (1.32–3.07)	–
Receipt of adjuvant chemotherapy	0.66 (0.55–0.78)	–
Operative factors
Type of colectomy
Right	Reference	Reference
Left	1.15 (1.00–1.33)	1.04 (0.86–1.27)
Partial	1.30 (0.94–1.79)	1.13 (0.74–1.73)
Total	1.15 (0.64–2.06)	1.10 (0.51–2.37)
Operative approach
Open	Reference	Reference
Minimally invasive	0.77 (0.63–0.94)	0.89 (0.68–1.16)
Year of surgery
2004–2005	Reference	Reference
2006–2007	0.86 (0.72–1.01)	0.92 (0.74–1.15)
2008–2009	0.92 (0.78–1.10)	0.85 (0.67, 1.09)
2010–2011	0.61 (0.50–0.76)	0.51 (0.38–0.68)
Surgeon factors
Board-certification
Surgery	Reference	Reference
Colorectal surgery	0.77 (0.62–0.94)	0.82 (0.62–1.07)
Annual colon cancer resection volume
Low (1–5)	Reference	Reference
Medium (5–10)	0.86 (0.74–1.01)	1.11 (0.89–1.38)
High (>10)	0.83 (0.71–0.98)	1.09 (0.87–1.37)

Discussion

This study investigated the relationship among age, postoperative complications, 1-year survival, and cause of death following potentially curative colon cancer surgery. Increasing age was independently associated with higher odds of a complication, and both increasing age and complications were independently associated with higher 1-year overall mortality as well as higher 1-year colon cancer and cardiovascular disease-specific mortality. In particular, infectious complications were associated with higher risk of death due to colon cancer and cardiovascular disease, and nearly one in four patients ⩾75 years old who suffered a complication died within 1 year. Furthermore, increasing age was associated with a decrease in the proportion of patients who died from colon cancer with a concomitant increase in the proportion of patients who died from cardiovascular disease. Given these relationships among age, complications, 1-year survival, and cause of death, these data highlight the importance of preoperative geriatric assessment, multidisciplinary patient care among surgeons, primary care physicians, and medical oncologists, and cardiovascular optimisation of older patients and those who suffer from sepsis.

Relation to other studies

Although this is the first large study in the United States to investigate 1-year survival and cause of death following colon cancer surgery, the 1-year mortality rate is similar to that of population-based European studies. One-year mortality rates ranged from 11.9 to 14% in studies from The Netherlands and the United Kingdom (Dekker , 2014; Gooiker ; Mamidanna ). These rates are similar to the 11.6% 1-year overall mortality rate in the current study when including those who died within 30 days of surgery. In the only other study to also look at cause of death, Dekker et al observed that 1-year mortality increased with patient age, 75% of deaths were attributed to colorectal cancer, and 25% of deaths were attributed to postoperative complications among 1924 patients who underwent stage I–III colorectal cancer resection in The Netherlands between 2006 and 2008 (Dekker ). Because the number of deaths coded as being due to colorectal cancer appeared too high to be due to cancer recurrence, the authors concluded that the excess mortality was due to a prolonged impact of surgery, especially in the elderly population. Using a similar study cohort, the same research group also found that older patients who survived at least 1 year following colorectal cancer surgery had similar long-term cancer-related survival to that of younger patients, suggesting that differences in long-term survival across age groups were due to deaths within the first postoperative year (Dekker ). These findings, as well as that of the current study, highlight the importance of preoperative CGA and multidisciplinary care among healthcare providers in the postoperative period as these strategies may not only improve 1-year survival but also long-term survival in the older surgical population.

Strategies to improve survival

The benefits of CGA, which measure activities of daily living (ADLs), instrumental ADLs (IADLs), depression, cognition, nutrition, and physical performance, have been demonstrated for elderly patients admitted to the hospital (Extermann, 2010; Ellis ). In a Cochrane meta-analysis of 10 315 patients from 22 trials comparing CGA with standard care, patients who received CGA were less likely to suffer death or deterioration (OR=0.76, 95% CI=0.64–0.90), less likely to be institutionalised (OR=0.79, 95% CI=0.69–0.88), and more likely to be alive and in their own homes after 12 months of follow-up (OR=1.16, 95% CI=1.05–1.28; Ellis ). Although fewer studies have focused on the surgical population, a recent systematic review suggests that the use of CGA may reduce medical complications and length of stay following elective surgery (Partridge ). In one of the randomised controlled trials included in the review, CGA reduced the rate of complications by 11.8% and the time to ‘fit for discharge' by 0.5 days in patients undergoing elective orthopaedic surgery (Huddleston ). In addition, the use of preoperative geriatric assessment markers to assess patient frailty has demonstrated good predictive ability for postoperative complications, discharge to a nursing facility, and 6-month mortality in patients undergoing major surgery (Robinson ; Makary ; Oresanya ).

Determining which patients are at risk for adverse postoperative events using CGA can also help guide preoperative and postoperative management of surgical patients in several other ways. In the preoperative setting, given that a large proportion of older patients die from cardiovascular disease, CGA and cardiovascular optimisation before surgery could help prevent adverse events. In addition, selecting appropriate patients for prehabilitation may improve functional status and subsequent postoperative outcomes. In a randomised controlled trial that included 77 patients undergoing colorectal cancer resection, Gillis et al observed that a higher proportion of patients who underwent prehabilitation recovered to or above baseline exercise capacity at 8 weeks compared with those who underwent rehabilitation after surgery (84% vs 62%, P=0.049; Gillis ). As aforementioned, CGA and involvement of geriatricians in postoperative care for selected patients may help lower postoperative complication rates and length of stay (Huddleston ; Partridge ). Furthermore, there is evidence from the United Kingdom that CGA is associated with higher rates of chemotherapy completion and fewer treatment modifications in patients ⩾70 years old (Kalsi ). This is particularly important as the present study observed that only 33% of patients ⩾75 year old, which comprised 44% of the study cohort, received adjuvant chemotherapy for stage III disease, and receipt of adjuvant chemotherapy significantly reduced the risk of 1-year overall and cancer-specific mortality. Due to a lack of compliance to evidence-based recommendations, an aging population, and a growing demand for cancer care, the Institute of Medicine recently declared that U.S. cancer care is in a state of crisis (Levit ). Auditing and feedback regarding quality indicators, such as adjuvant chemotherapy administration for stage III disease, may help improve healthcare delivery and performance (Cirocco ).

Although older patients undergoing elective colon cancer resection may benefit from CGA and prehabilitation, another important finding in this study was that older patients were more likely to undergo colon cancer resection during an unscheduled admission. Previous studies have indicated that non-elective colon cancer surgery is associated with worse survival, and non-elective presentation would preclude the use of preoperative CGA and prehabilitation (Gooiker ; Dekker ). This finding highlights the importance of adherence to colon cancer screening guidelines. In addition, older patients were more likely to undergo open colectomy and have surgery at rural or non-academic institutions. An open approach has been shown to have higher morbidity compared with a minimally invasive approach, and rural and non-academic institutions may not have the resource availability for CGA, prehabilitation, and multidisciplinary care (Bilimoria ). Identifying strategies to improve adherence to colon cancer screening guidelines to limit the number of non-elective colon cancer resections, increase the rate of a minimally invasive approach, and either increase resource availability or develop a standardised algorithm to select patients for CGA and prehabilitation may further improve outcomes for older patients.

Given that cardiovascular disease was the second-leading cause of 1-year mortality following colon cancer surgery, CGA, multidisciplinary care, and management of patient comorbidities among surgeons, primary care physicians, and medical oncologists may further help improve patient survival (Kim ; Brar ). Because 66% of the study cohort had stage I or II colon cancer, it is plausible that the majority of patients never saw a medical oncologist following surgery. If these patients are elderly, have medical comorbidities, or are current smokers and do not have regular follow-up with their primary care physicians, they may be at higher risk for cardiovascular events in the postoperative period as their medical conditions are not being optimally managed. A recent study found that hypertension, diabetes mellitus, and smoking history were the strongest predictors of cardiovascular disease in breast cancer survivors ⩾65 years old (Haque ). Not surprisingly, several studies have observed that cancer patients with a comorbidity had worse 5-year survival compared with those without comorbidity, with hazard ratios ranging from 1.1 to 5.8 (Finlayson ; Sogaard ). Furthermore, older age was associated with septic complications in the present study, and there is increasing evidence that sepsis is not only associated with an increased risk of cancer-related mortality but also cardiovascular events (Yende ; Ou ; Park ). The underlying mechanism for this cardiovascular risk is thought to be due to sepsis-mediated systemic inflammation. There has been some evidence that the use of statins may suppress the inflammatory response to sepsis, thus reducing the risk of cardiovascular events (Steiner ). However, further studies investigating the use of statins in sepsis survivorship are needed.

Study weaknesses and strengths

Although this exploratory study identified several potential targets to improve survival following colon cancer surgery, it has several limitations. First, SPARCS relies on administrative coding and does not include a comprehensive list of comorbidities, physician and patient decision-making, or information regarding patient functional dependence, ADLs, IADLs, and frailty. In addition, the timing of postoperative complications with respect to the date of surgery is not captured in SPARCS. Furthermore, although information regarding receipt of adjuvant chemotherapy is available, there is no data regarding the number of cycles or which chemotherapy agents were administered. Notwithstanding these limitations, this is the largest study in the United States to investigate the relationship among age, postoperative complications, 1-year survival, and cause of death following colon cancer surgery. In addition, SPARCS is an all-payer database including patients of all ages, and the data are linked to the state cancer registry to obtain information regarding oncologic staging and adjuvant therapy. It is also linked to the National Death Index, which enables capturing of the date and cause of death for patients as long as they died within the United States, which is an advantage over single-institution studies which may have limited follow-up.

Conclusions

This study demonstrated that older age is independently associated with higher odds of postoperative complications, and older age and complications, in particular sepsis, are associated with higher rates of 1-year overall, cancer-specific, and cardiovascular disease-specific mortality following potentially curative colon cancer surgery. These findings highlight the importance of CGA and multidisciplinary care among surgeons, primary care physicians, and oncologists for older patients. The study also demonstrates the need for future work identifying methods of cardiovascular optimisation in elderly patients and sepsis survivors following surgery given their increased risk of 1-year mortality from cardiovascular disease.